GAS5 and gastric cancer: GAS5, an lncRNA of approximately 650 bp, has been shown to be significantly down-regulated in gastric cancer tissues compared with corresponding normal tissues [58], and this decreased expression has been shown to be associated with a large tumour size, advanced pathologic stage, and poorer DFS and OS.